BiosensIC ApS: Financial statements 2025
CVR: 41757884
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BiosensIC ApS (CVR 41757884) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -12,099 and a net result of DKK -13,647 compared with DKK -5,629 the year before. Equity in the 2025 report amounted to DKK -54,898.
- Revenue
- DKK 0
- Gross Profit
- DKK -12,099
- Profit/Loss
- DKK -13,647
- Equity
- DKK -54,898
- Total Assets
- DKK 16,708
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | -12 t. | -14 t. | -55 t. | - |
| 2024 | 0 | -2 t. | -6 t. | -41 t. | - |
| 2023 | 0 | -2 t. | -18 t. | -36 t. | - |
| 2022 | - | -2 t. | -19 t. | -17 t. | - |
Official annual report
How creditworthy is BiosensIC ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BiosensIC ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -5,629.
About BiosensIC ApS
BiosensIC ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Allan Nogueras Nielsen and Leiying Zhu. The company is owned by Allan Nogueras Nielsen and Leiying Zhu. In 2025, the company reported a gross profit of DKK -12,099 and a net result of DKK -13,647 compared with DKK -5,629 the year before. Equity in the 2025 report amounted to DKK -54,898.